Have some news you want to share with the Oregon Bio community? Fill out our submission form.
Taconic to distribute Yecuris Corporation human xenograft FRG™ KO mouse technologies in the US and Europe
Hudson, New York and Portland, Oregon, February 26, 2013 – Taconic and Yecuris Corporation announce the formation of an exclusive marketing and distribution agreement to provide access to the Yecuris FRG™ KO animal portfolio. The agreement allows Taconic to promote and sell FRG™ primary cell xenograft animal models and HepaCur™ human primary hepatocytes developed by Yecuris Corporation for use in in vivo and in vitro […]
Moss Adams LLP
Certified Public Accountants
February 2013 – MA Alert
A 2.3 percent tax on the sale of certain medical devices in the United States went into effect January 1 despite efforts from opponents to repeal or delay its implementation. The tax—part of the 2010 health care reform law and codified under Section 4191 of the Internal Revenue Code (IRC)—applies to the sale of taxable medical devices by their manufacturer, producer, or importer.
On December 5, 2012, the US Department of the […]
DesignMedix is pleased to announce the appointment of Erik Iverson to the board of directors. Mr. Iverson is Executive Vice President, Business Development and External Affairs at the Infectious Disease Research Institute (IDRI) headquartered in Seattle, Washington, a global health research institute developing diagnostics, vaccines, and treatments for neglected diseases of poverty. Prior to joining IDRI, he was Associate General Counsel at the Bill & Melinda Gates Foundation where he led the development and implementation of the Foundation’s Global Access […]
Genetic Engineering & Biotechnology News
Insight & Intelligence: Jan 24, 2013
SBIR Thinks Smaller
New rules taking effect on January 28 aim to draw investor-owned smaller biopharmas to the federal grant program and STTR, its companion.
Monday, January 28, marks a new era for the U.S. Small Business Innovation Research (SBIR) program, as new rules take effect that are designed to draw more small businesses in biopharma and other technologies to SBIR and its companion Small Business Technology Transfer (STTR).
The changes were written more […]
WILSONVILLE, Ore., Jan. 16, 2013 /PRNewswire-iReach/ — SAM Medical Products, Wilsonville, Oregon, has sold a minority stake in the company to the Confederated Tribes of Grand Ronde. The cash investment will allow SAM Medical to accelerate new product development, and to expand their marketing and sales capabilities over the next five years.
SAM Medical Products President, Adrian Polliack , says of the opportunity “The Grand Ronde Tribal Council and Economic Development unit are very business savvy and the fact they are […]
Oregon Business Magazine by Linda Baker
Date: January 2013
Multiple sclerosis is an immune disorder in which the body mistakenly attacks the myelin sheath surrounding nerve fibers in the brain and spinal cord. The resulting neurological symptoms can range from numbness and tingling to paralysis. Although existing therapies reduce inflammation caused by MS, researchers have long sought to develop a therapy that will actually repair the neurological damage.
Enter Artielle ImmunoTherapeutics, a Portland biotech company that will launch an FDA phase-two clinical trial […]
Portland Business Journal by Susanne Stevens, Web Editor
Date: Thursday, December 13, 2013, 7:22 a.m. PST
Reed College will use a $3 million gift from Amgen to create a chair of chemical biology.
The California-based biotech company donated the money in honor of Roger Perlmutter, a former Amgen executive vice president of research and development and a Reed alum.
The donation for what will be named the Amgen-Perlmutter Chair is the largest corporate gift in Reed’s history.
“I owe my interest in fundamental research to […]
LAKE OSWEGO, Ore., Dec. 4, 2012 (GLOBE NEWSWIRE) — Galena Biopharma, Inc. (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments, today announced it has signed an agreement with a subsidiary of Teva Pharmaceutical Industries Limited for the commercialization of NeuVax™ (nelipepimut-S or E75) in Israel.
“This agreement is the first piece of our global commercialization strategy,” said Mark Ahn, Ph.D., President and Chief Executive Officer, Galena Biopharma. “Teva is a world-class pharmaceutical company and a major pharmaceutical company […]
Portland Business Journal by Andy Giegerich , Business Journal staff writer
Date: Thursday, November 29, 2012, 2:28pm PST – Last Modified: Thursday, November 29, 2012, 3:05pm PST
A new bioscience industry incubator, the state’s first, will cap a busy year for Oregon’s suddenly bustling biotechnology sector.
The Oregon Translational Research and Development Institute will open the biotech incubator in Portland’s South Waterfront District. OTRADI is a state-funded effort to commercialize various research.
As we’ve reported recently, the state’s biotech industry is surging, with a […]
Oregon Bio 2012: Bioscience Digitization and Discovery features 45 world-renowned speakers, with a focus on digital platforms, a look at the “Hunger Games,” investor pitching, and STEM education at the Oct. 9 and 10 event
FOR IMMEDIATE RELEASE – October 5, 2012
CONTACT: Dennis McNannay, executive director, Oregon Bio, 503.548.4432
Dianne Danowski Smith, APR, board member, Oregon Bio, 503.201.7019
Adrienne Webb, OTRADI, 541.954.4919
(Portland, Ore.) — Governor John Kitzhaber has proclaimed Tuesday, Oct. 9, 2012, as “Oregon Digital Health and Bioscience Day,” kicking off Oregon’s […]